The frequency in the population now is approaching 8%, up from about 5% a decade ago.
Read More »Diabetes In Control
Issue 144 Item 11 Beta-Cell Death Outpaces Replacement in Type 2 Diabetes
Approaches designed to arrest beta-cell apoptosis could be a “significant new development in the management of type 2 diabetes.
Read More »Issue 144 Item 10 Rosuvastatin Reduces LDL Cholesterol and Improves Lipid Profil
Rosuvastatin (Crestor; AstraZeneca) is more effective than atorvastatin (Lipitor; Pfizer, Inc.)
Read More »Issue 143 Item 5 Intensive Treatment at Onset of Diagnosis of Diabetes Improves
Primary care providers do not appear to manage diabetes diagnosed at screening as intensively as long-standing diabetes.
Read More »Issue 144 Item 9 Obesity & Poor Glycemic Control Common for African-American Typ
Average baseline HbA1c levels were 9.9% in patients aged less than 30 years.
Read More »Sugar Key to Memory Problems
Helps to explain why memory loss occurs as we age.
Read More »Issue 144 Item 8 Pancreatic Beta Cell Destruction Prevented by Natural Killer T
Natural killer T cells (NKT cells) prevented the development of diabetes, according to a report from researchers in France.
Read More »Issue 143 Item 3 Ibuprofen Could Be Bad for Heart Patients WARN YOYR PATIENTS!
Patients who take low-dose aspirin for cardioprotection should not take ibuprofen.
Read More »Issue 144 Item 7 Lack of Diabetes Patient Education Standardization Responsible
Physicians need to take a more active role.
Read More »Issue 143 Item 2 Young Adults with Insulin treated Diabetes have Elevated Stroke
People with insulin-dependent (type 1) diabetes have an increased risk of dying from a stroke, according to first-time findings from a large, community-based study.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.